Erratum to: A Phase 1 dose-escalation study of the safety and pharmacokinetics of once-daily oral foretinib, a multi-kinase inhibitor, in patients with solid tumors

Source: Investigational New Drugs - Category: Drugs & Pharmacology Source Type: research